McKesson Corporation (0JZU.L)
USD 670.32
(2.06%)
USD 670.32
(2.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 69.04 Billion USD | 8.2% |
| 2022 | 63.81 Billion USD | -1.97% |
| 2021 | 65.09 Billion USD | 2.39% |
| 2020 | 63.56 Billion USD | 16.56% |
| 2019 | 54.53 Billion USD | 9.09% |
| 2018 | 49.99 Billion USD | 2.31% |
| 2017 | 48.86 Billion USD | 1.03% |
| 2016 | 48.36 Billion USD | 4.9% |
| 2015 | 46.1 Billion USD | 3.85% |
| 2014 | 44.39 Billion USD | 7.14% |
| 2013 | 41.44 Billion USD | 49.52% |
| 2012 | 27.71 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 73.05 Billion USD | 5.81% |
| 2023 Q1 | 65.33 Billion USD | 2.39% |
| 2023 Q4 | 69.04 Billion USD | 1.24% |
| 2023 Q3 | 68.19 Billion USD | 0.95% |
| 2023 Q2 | 67.55 Billion USD | 3.4% |
| 2023 FY | 69.04 Billion USD | 8.2% |
| 2022 FY | 63.81 Billion USD | -1.97% |
| 2022 Q3 | 64.77 Billion USD | 0.7% |
| 2022 Q2 | 64.33 Billion USD | 0.88% |
| 2022 Q1 | 63.76 Billion USD | -2.03% |
| 2022 Q4 | 63.81 Billion USD | -1.5% |
| 2021 Q2 | 63.68 Billion USD | 1.2% |
| 2021 Q1 | 62.93 Billion USD | -1.0% |
| 2021 FY | 65.09 Billion USD | 2.39% |
| 2021 Q3 | 64.49 Billion USD | 1.27% |
| 2021 Q4 | 65.09 Billion USD | 0.92% |
| 2020 Q2 | 54.2 Billion USD | 7.12% |
| 2020 Q3 | 60.83 Billion USD | 12.23% |
| 2020 Q4 | 63.56 Billion USD | 4.5% |
| 2020 FY | 63.56 Billion USD | 16.56% |
| 2020 Q1 | 50.59 Billion USD | -7.22% |
| 2019 FY | 54.53 Billion USD | 9.09% |
| 2019 Q3 | 53.09 Billion USD | 4.27% |
| 2019 Q4 | 54.53 Billion USD | 2.72% |
| 2019 Q1 | 52.21 Billion USD | 4.44% |
| 2019 Q2 | 50.91 Billion USD | -2.48% |
| 2018 Q3 | 50.21 Billion USD | -0.5% |
| 2018 FY | 49.99 Billion USD | 2.31% |
| 2018 Q1 | 50.21 Billion USD | 2.76% |
| 2018 Q2 | 50.47 Billion USD | 0.52% |
| 2018 Q4 | 49.99 Billion USD | -0.45% |
| 2017 Q3 | 50.8 Billion USD | -0.5% |
| 2017 Q4 | 48.86 Billion USD | -3.82% |
| 2017 FY | 48.86 Billion USD | 1.03% |
| 2017 Q1 | 48.91 Billion USD | 1.12% |
| 2017 Q2 | 51.06 Billion USD | 4.39% |
| 2016 Q1 | 47.07 Billion USD | 2.09% |
| 2016 Q4 | 48.36 Billion USD | -0.7% |
| 2016 Q3 | 48.71 Billion USD | 2.87% |
| 2016 FY | 48.36 Billion USD | 4.9% |
| 2016 Q2 | 47.35 Billion USD | 0.59% |
| 2015 FY | 46.1 Billion USD | 3.85% |
| 2015 Q4 | 46.1 Billion USD | 3.04% |
| 2015 Q3 | 44.74 Billion USD | -1.73% |
| 2015 Q2 | 45.53 Billion USD | -0.04% |
| 2015 Q1 | 45.55 Billion USD | 2.61% |
| 2014 Q1 | 42.24 Billion USD | 1.93% |
| 2014 Q4 | 44.39 Billion USD | -0.21% |
| 2014 Q3 | 44.49 Billion USD | 6.68% |
| 2014 Q2 | 41.7 Billion USD | -1.27% |
| 2014 FY | 44.39 Billion USD | 7.14% |
| 2013 Q1 | 28.08 Billion USD | 1.32% |
| 2013 Q2 | 27.95 Billion USD | -0.45% |
| 2013 Q3 | 28.45 Billion USD | 1.77% |
| 2013 Q4 | 41.44 Billion USD | 45.65% |
| 2013 FY | 41.44 Billion USD | 49.52% |
| 2012 Q4 | 27.71 Billion USD | 7.49% |
| 2012 Q3 | 25.78 Billion USD | 0.0% |
| 2012 FY | 27.71 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -57610.054% |
| Accuray Incorporated | 423.54 Million USD | -16201.06% |
| Align Technology, Inc. | 2.45 Billion USD | -2714.149% |
| Elevance Health Inc. | 69.52 Billion USD | 0.692% |
| AxoGen, Inc. | 101.16 Million USD | -68148.947% |
| Boston Scientific Corporation | 15.6 Billion USD | -342.407% |
| CVS Health Corporation | 173.09 Billion USD | 60.113% |
| Cardinal Health, Inc. | 48.33 Billion USD | -42.847% |
| Centene Corporation | 58.68 Billion USD | -17.648% |
| DaVita Inc. | 14.87 Billion USD | -364.113% |
| HCA Healthcare, Inc. | 55.15 Billion USD | -25.187% |
| Hologic, Inc. | 4.02 Billion USD | -1614.903% |
| Humana Inc. | 30.74 Billion USD | -124.549% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -3788.825% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -681.495% |
| Masimo Corporation | 1.67 Billion USD | -4017.731% |
| Patterson Companies, Inc. | 1.89 Billion USD | -3543.377% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -807.969% |
| ResMed Inc. | 2 Billion USD | -3337.746% |
| Henry Schein, Inc. | 5.42 Billion USD | -1173.838% |
| Teladoc Health, Inc. | 2.06 Billion USD | -3241.341% |
| Universal Health Services, Inc. | 8.15 Billion USD | -746.628% |
| Veeva Systems Inc. | 1.26 Billion USD | -5353.141% |
| Baxter International Inc. | 19.8 Billion USD | -248.556% |
| Becton, Dickinson and Company | 26.98 Billion USD | -155.863% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -3277.458% |
| Danaher Corporation | 30.99 Billion USD | -122.73% |
| Stryker Corporation | 21.31 Billion USD | -223.852% |
| Medtronic plc | 39.56 Billion USD | -74.52% |